NCT07124702 Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy
| NCT ID | NCT07124702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State University of New York at Buffalo |
| Condition | Dual Use of Cigarettes and E-cigarettes |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2025-10-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We propose a randomized controlled trial to develop and evaluate a cessation program with two different strategies for dual users during pregnancy. We plan to enroll 45 pregnant mothers (≤20 gestational weeks) with low household incomes from the Western NY region. To be eligible, they must be currently dual using CCs and nicotine-containing ECs. These mothers will be randomized into one of three groups: 1) simultaneous cessation intervention group (N=15), 2) stepwise cessation intervention group (N=15), and 3) control group (N=15). We hypothesize that nicotine abstinence rates at 8 weeks after randomization will be higher in the intervention groups than in the control group.
Eligibility Criteria
Inclusion Criteria: * Less than 21 weeks pregnant to ensure adequate time for intervention; * 18 years or older; * Actively using both cigarettes and electronic cigarettes (e-cigarettes); * Willing to receive cessation information; * Able to read, understand, and speak English; * Having a low household income defined as ≤185% of the federal poverty level. Exclusion Criteria: * Teen pregnancy (\<18 y); * Unstable housing; * Uncontrolled mental health disorders; * Non-English speakers.
Contact & Investigator
Xiaozhong Wen, PhD
PRINCIPAL INVESTIGATOR
State University of New York at Buffalo
Frequently Asked Questions
Who can join the NCT07124702 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Dual Use of Cigarettes and E-cigarettes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07124702 currently recruiting?
Yes, NCT07124702 is actively recruiting participants. Contact the research team at xiaozhon@buffalo.edu for enrollment information.
Where is the NCT07124702 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT07124702 clinical trial?
NCT07124702 is sponsored by State University of New York at Buffalo. The principal investigator is Xiaozhong Wen, PhD at State University of New York at Buffalo. The trial plans to enroll 45 participants.